Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
1,268
1,268 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- XNW28012Phase 32 trials
Evopoint Biosciences Inc. · Pancreatic Cancer, Advanced Solid Tumors, Pancreatic Carcinoma
- XZP-3287Phase 32 trials
Xuanzhu Biopharmaceutical Co., Ltd. · Advanced Breast Cancer
- ZN-A-1041ZN-A-1041 Enteric, RO7771950Phase 32 trials
Roche (Genentech) · HER2-positive Breast Cancer, Advanced Solid Tumors
- ABBV-1480Phase 31 trial
AbbVie · Non-Small Cell Lung Cancer
- AcasunlimabGEN1046, DuoBody-PD-L1×4-1BBPhase 31 trial
Genmab · PD-L1-positive, Locally Advanced (Unresectable Stage IIIB/C) or Metastatic NSCLC
- adebelizumabPhase 31 trial
Suzhou Suncadia Biopharmaceuticals Co., Ltd. · Advanced or Metastatic Non-small Cell Lung Cancer
- AK105Phase 31 trial
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Advanced Hepatocellular Carcinoma (HCC)
- albumin binding paclitaxelPhase 31 trial
Jiangsu Healthy Life Innovation Medical Technology Co., Ltd · Locally Advanced Pancreatic Cancer
- Alflutinib MesylatePhase 31 trial
Allist Pharmaceuticals, Inc. · Locally Advanced or Metastatic EGFR Sensitising Mutation Positive Non-small Cell Lung Cancer
- arboplatinPhase 31 trial
Hansoh BioMedical R&D Company · Platinum-sensitive Recurrent Ovarian Cancer
- ASP2138Phase 31 trial
Astellas · Gastric Adenocarcinoma, Gastroesophageal Junction (GEJ) Adenocarcinoma
- ASTX030cedazuridine + azacitidinePhase 31 trial
Taiho Oncology, Inc. · Myelodysplastic Syndromes, Acute Myeloid Leukemia, Myelodysplastic Syndrome/Neoplasm
- Atezolizumab followed by AtezolizumabPhase 31 trial
SystImmune Inc. · Small Cell Lung Cancer Extensive Stage, Small-cell Lung Cancer, Small Cell Carcinoma
- Atigotatug+NivolumabBMS-986489Phase 31 trial
Bristol Myers Squibb · Extensive-Stage Small Cell Lung Cancer
- BecavizumabPhase 31 trial
Roche (Genentech) · Hepatocellular Carcinoma
- BemarituzumabPhase 31 trial
Amgen · Gastric Cancer, Gastroesophageal Junction Adenocarcinoma
- BGB-43395Phase 31 trial
BeOne Medicines (BeiGene) · HR+/HER2- Breast Cancer
- BMS-986365Phase 31 trial
Bristol Myers Squibb · Metastatic Castration-resistant Prostate Cancer
- BNT113Phase 31 trial
BioNTech SE · Unresectable Head and Neck Squamous Cell Carcinoma, Metastatic Head and Neck Cancer, Recurrent Head and Neck Cancer
- Buparlisib & PaclitaxelAN2025Phase 31 trial
Adlai Nortye Biopharma Co., Ltd. · Head and Neck Cancer
- camrelizumab; famitinib malatePhase 31 trial
Jiangsu HengRui Medicine Co., Ltd. · Cervical Cancer
- D07001-SoftgelPhase 31 trial
InnoPharmax Inc. · Biliary Tract Cancer (BTC)
- DalpciclibPhase 31 trial
Jiangsu HengRui Medicine Co., Ltd. · Breast Cancer
- DalpiciclibPhase 31 trial
Risen (Suzhou) Pharma Tech Co., Ltd. · Breast Cancer
- DeutenzalutamidePhase 31 trial
AstraZeneca · Metastatic Castration-resistant Prostate Cancer
- EU-authorized NivolumabPhase 31 trial
Amgen · Melanoma
- F520Phase 31 trial
Shandong New Time Pharmaceutical Co., LTD · Cancer of Unknown Primary Site
- FDA-licensed NivolumabPhase 31 trial
Amgen · Melanoma
- FDA018-ADCPhase 31 trial
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. · Triple Negative Breast Cancer
- FHND9041Phase 31 trial
Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. · Non Small Cell Lung Cancer
- FiclatuzumabAV-299Phase 31 trial
AVEO Pharmaceuticals, Inc. · Metastatic Head-and-neck Squamous-cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma
- Fixed of PertuzumabPhase 31 trial
Roche (Genentech) · Early Breast Cancer, Locally Advanced Breast Cancer, Inflammatory Breast Cancer
- FuzuloparibPhase 31 trial
Jiangsu HengRui Medicine Co., Ltd. · Metastatic Castration-Resistant Prostate Cancer (mCRPC)
- GB491Phase 31 trial
Genor Biopharma Co., Ltd. · Breast Cancer
- GLSI-100Phase 31 trial
Greenwich LifeSciences, Inc. · Breast Cancer
- GQ1005Phase 31 trial
GeneQuantum Healthcare (Suzhou) Co., Ltd. · HER2-positive Breast Cancer
- Hemay022Phase 31 trial
Tianjin Hemay Pharmaceutical Co., Ltd · Breast Cancer
- HLX11Phase 31 trial
Shanghai Henlius Biotech · Breast Cancer, Breast Neoplasms, HER2-positive Breast Cancer
- HLX13Phase 31 trial
Shanghai Henlius Biotech · Hepatocellular Carcinoma (HCC)
- HLX17Phase 31 trial
Shanghai Henlius Biotech · Non-Squamous Non-Small Cell Lung Cancer
- HR070803Phase 31 trial
Jiangsu HengRui Medicine Co., Ltd. · Colorectal Cancer
- HR20013Phase 31 trial
Fujian Shengdi Pharmaceutical Co., Ltd. · Nausea and Vomiting Associated With Moderate Emetic Risk Anticancer Agents
- HRS-4357Phase 31 trial
Jiangsu HengRui Medicine Co., Ltd. · PSMA-Positive Progressive Metastatic Castration-Resistant Prostate Cancer
- HS-10370Phase 31 trial
Jiangsu Hansoh Pharmaceutical Co., Ltd. · Carcinoma, Non-Small-Cell Lung
- HS-20117PM1080Phase 31 trial
Hansoh BioMedical R&D Company · Non-Squamous Non-Small Cell Lung Cancer
- HS627Phase 31 trial
BioRay Pharmaceutical Co., Ltd. · Breast Cancer
- HX22Phase 31 trial
Shanghai Henlius Biotech · HER2 + Breast Cancer
- IAH0968Phase 31 trial
SUNHO(China)BioPharmaceutical CO., Ltd. · Stomach Neoplasms, Solid Tumor
- IcotinibPhase 31 trial
Betta Pharmaceuticals Co., Ltd. · Non-Small Cell Lung Cancer, EGFR Sensitive Mutation, Adjuvant Therapy
- IDRX-42velzatinib - subject to USAN approvalPhase 31 trial
GSK · Gastrointestinal Neoplasms
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.